POSTER SESSION VI
Wednesday, March 28, 2007 — 1:00 PM - 4:00 PM
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
DERMATOPATHOLOGY
Poster#
Title and Authors
Itinerary Planner
62
Comparison of PHH3, Ki-67 and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions
(428)
MR Nasr, OA El-Zammar - SUNY Upstate Medical University, Syracuse, NY
Overexpression of Focal Adhesion Kinase in Primary Cutaneous Melanoma
(412)
SM Homan, O Cano, A Aplin, C Cohen, JA Carlson - Albany Medical College, Albany, NY; Emory University, Atlanta, GA
Targeting Bfl-1 Expression Inhibits Melanoma Cell Survival
(399)
N Chen, R Huang, XQ Chen, H Zeng, J Gong, Y Huang, YT He, Q Zhou - West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China
Expression of S100 Protein Subtypes in Desmoplastic Melanoma, Neurofibroma and Schwannoma
(401)
L Chiriboga, H Yee, D Nonaka - New York University Medical Center/New York University School of Medicine, New York, NY
ErBb Receptor Family Expression in Melanocytic Lesions
(407)
M Feinmesser, V Veltman, A Tobar, S Morgenstern, H Gutman, E Kaganovsky, C Tzabari, J Sulkes, E Okon - Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Petah Tiqva, Israel
Overexpression of FGF-2 May Confer a Survival Advantage to Tumor Cells in Melanoma and Dysplastic Nevus with Regression
(433)
MA Sajid, D Ivan, O Erdem, AH Diwan, VG Prieto - University of Texas Health Science Center, Houston, TX; University of Texas - MD Anderson Cancer Center, Houston, TX
Lymphatic Invasion Revealed by Multispectral Imaging Is Common in Primary Melanomas and Associates with Prognosis
(441)
X Xu, PA Gimotty, D Guerry, P VanBelle, H Liang, K Montone, T Pasha, M Ming, G Acs, M Feldman, S Barth, R Hammond, R Elenetsis, PJ Zhang, DE Elder - University of Pennsylvania, Philadelphia, PA
Melanocytic “Ball-in-Mitts” and “Microalveolar Structures” and Their Role in the Development of Cellular Blue Nevi
(417)
DV Kazakov, M Michal - Charles University, Pilsen, Czech Republic
Neurothekeoma: An Analysis of 178 Tumors with Detailed Immunohistochemical Data and Long-Term Patient Follow-Up Information
(408)
JF Fetsch, WB Laskin, JR Hallman, GP Lupton, M Miettinen - Armed Forces Institute of Pathology, Washington, DC; Feinberg School of Medicine, Chicago, IL
A Case Series and Immunophenotypic Analysis of CK20-/CK7+ Primary Neuroendocrine Carcinoma of the Skin
(396)
KB Calder, S Coplowitz, S Schlauder, MB Morgan - University of South Florida College of Medicine, Tampa, FL; James A. Haley Veterans Hospital, Tampa, FL
Identification of Genomic Predictors of Non-Melanoma Skin Cancer in Solid Organ Transplant Recipients
(418)
C Kepron, P Reis, R Bharadwaj, J Shaw, S Kamel-Reid, D Ghazarian - University of Toronto, Toronto, ON, Canada
CD10 Immunoexpression in Cutaneous Spindle Cell Neoplasms
(409)
DL Gardner, M Petitt, CH Palmer, BE Faulkner-Jones - University of New Mexico School of Medicine, Albuquerque, NM; Presbyterian Health Care Services, Albuquerque, NM
Pax-2 Expression in Cutaneous Adnexal Neoplasms
(442)
LD Young, MT Sharp, KM Hiatt - University of Mississippi Medical Center, Jackson, MI; University of Arkansas for Medical Sciences, Little Rock, AR
Cutaneous Neoplasms with Pagetoid Cells: An Immunohistochemical Study of Mammaglobin Expression
(391)
S Bahrami, S Badve, J Cotton, SD Billings - Indiana University, Indianapolis, IN; St. Joseph Mercy Hospital, Ann Arbor, MI
Alpha-Methylacyl Coenzyme A Racemase Is Immunoreactive in Extramammary Paget’s Disease
(423)
DC Mayes, JW Patterson, DM Ramnani, SE Mills - University of Virginia Health System, Charlottesville, VA; Virginia Urology, Richmond, VA
Cutaneous Extra-Ocular Sebaceous Carcinoma: A Less Aggressive Neoplasm Than Previously Asserted
(424)
PS Mecca, JR Shia, R Delgado, KJ Busam - Memorial Sloan Kettering Cancer Center, New York, NY
Follicular Cutaneous Squamous Cell Carcinoma: An Under-Recognized Neoplasm Arising from Hair Appendage Structures
(435)
I Shendrik, AN Crowson, CM Magro - University of Oklahoma, Tulsa, OK; Regional Medical Laboratory, Tulsa, OK; Cornell University Medical Center, New York, NY
TdT Expression in Merkel Cell Carcinoma: Potential Diagnostic Pitfall with Blastic Hematological Malignancies and Expanded Immunohistochemical Analysis
(436)
M Sur, H AlArdati, C Ross, S Alowami - McMaster University, Hamilton, ON, Canada
Loss of Heterozygosity Analysis Identifies Genetic Abnormalities in Mycosis Fungoides and Specific Loci Associated with Disease Progression
(415)
TM Katona, L Cheng, DP O’Malley, KM Hiatt, M Wang, JJ Anagnostou, SD Billings, BR Smoller - Indiana University School of Medicine, Indianapolis, IN; University of Arkansas for Medical Sciences, Little Rock, AR
The Evaluation of T Regulatory Foxp3 Expression in Cutaneous T-Cell Lymphocytic Infiltrates
(390)
BD Amin, GJ Solomon, C Morrison, PL Porcu, CM Magro - Weill Medical College of Cornell University, New York, NY; The Ohio State University Medical School, Columbus, OH
PAX-5 and CD15 Can Distinguish between Type A Lymphomatoid Papulosis and Cutaneous Involvement by Hodgkin Lymphoma
(402)
KS Doeden, WD Howell, Y Kim, R Hoppe, Y Natkunam, UN Sundram - Stanford University, Stanford, CA
An Immunohistochemical Panel (Clusterin, CLA, and EMA) Useful in Diagnosing Cutaneous CD30+ Lymphoproliferations
(394)
JE Blankenship, RA Higgins, TL Davis, MC Kinney - University of Texas Health Science Center at San Antonio, San Antonio, TX; South Texas Dermatopathology Lab, San Antonio, TX
Cutaneous Marginal Zone Lymphoma with Marked Plasmacytic Differentiation and Rare B Cells
(437)
J Turbiner, L Zukerberg, NL Harris, T Flotte - Massachusetts General Hospital, Boston, MA
D2-40 Is Another Useful Marker in Differentiating Dermatofibroma from Dermatofibrosarcoma Protuberans
(398)
LJ Chan, XW Xu, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia, PA
Myxoid Dermatofibrosarcoma Protuberans: Clinicopathologic, Immunohistochemical, and Molecular Analysis of 6 Cases
(425)
T Mentzel, DV Kasakov, M Michal - Gemeinschaftspraxis, Friedrichshafen, Germany; University Hospital, Plzen, Czech Republic
The Utility of Apo D as a Diagnostic Immunohistochemical Adjunct in Dermatofibrosarcoma Protuberans
(421)
M Lisovsky, K Dresser, M Mahalingam - University of Massachusetts Medical School, Worcester, MA
Dermatofibrosarcoma Protuberans Treated with Wide Local Excision: Prognostic Significance of Clinicopathologic Variables
(406)
O Erdem, AJ Wyatt, VG Prieto - Gazi University, Ankara, Turkey; University of Texas -MD Anderson Cancer Center, Houston, TX
Lipodermatosclerosis: A Histological Study of 25 Cases
(440)
SN Walsh, A Cheng, J Petersen, DJ Santa Cruz - WCP Laboratories, Inc, St. Louis, MO; Washington University/Barnes-Jewish Hospital, St. Louis, MO
Sterile Neutrophilic Lobular Panniculitis: A Novel Subcutaneous Expression of the Acute Infectious ID Reaction
(403)
ME Dyrsen, AN Crowson, CM Magro - New York Presbyterian/Weill-Cornell Medical Center, New York, NY; Univ. of Oklahoma, Tulsa, OK
button next to any title to add to Itinerary Planner...
Add
